The effectual outcomes of AMPK induction in impeding tumor progression thus open a new door to advocating different combination strategies, including those duple-targeted remedies mentioned above, in the treatment of chemoresistance and carcinomatosis of ovarian cancer. Here, PRKAA1 is linked to neoplasm.